Brief: Ascelia Pharma Q2 Oper Loss Widens To SEK 28.6 Mln

Ascelia Pharma AB

20/08/2020 07:13

Aug 20 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * QUARTERLY REPORT Q2-2020: FIRST PARTICIPANT IN THE HEPATIC
STUDY
    * Q2 OPERATING RESULT OF SEK -28.6M (SEK -14.5M)

Source text for Eikon:  ID:nWkrnttV 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))